Oxidation products of DNA, lipid and protein among the individuals progressing towards metabolic syndrome by Bhutia, Rinchen D et al.
Indian Journal of Biochemistry & Biophysics 







Oxidation products of DNA, lipid and protein among the individuals progressing 
towards metabolic syndrome 
Rinchen D Bhutia*, Bidita Khandelwal, Mingma L Sherpa & TA Singh 
Department of Biochemistry, Medicine Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, 
Tadong, Gangtok -737 102, East Sikkim, India 
Received 15 November 2017; revised 03 December 2018 
Oxidative stress (OS) is an early event and at the same time also a consequence in the pathology of MetS. We 
investigated if oxidation markers of DNA, lipid and protein increased with an increase in the risk parameters of MetS. 
Participants (male:70, female:90 ≥ 20 yrs) were categorized based on the number of risk factors they had as 3 Risk, 2 Risk,  
1 Risk and 0 Risk for MetS and were evaluated for various oxidation markers. Protein carbonyl and advanced oxidation 
protein product (protein oxidation marker) differed significantly between the four study group while malondialdehyde and 
hydroxynonenal (lipid peroxidation marker) did not. ―8-OH dG‖ (DNA oxidation marker) differed significantly (P< 0.05) 
while total antioxidant capacity did not demonstrate significant difference in its values across the group (P> 0.05). Pairwise 
comparison for statistically significant markers(Protein oxidation markers and 8-OH dG), demonstrated that only 8-OH dG 
differed significantly between 0 Risk- 3 Risk (P< 0.012) but not between 0 Risk -2 Risk and 0 Risk-1 Risk. Oxidative stress 
markers of DNA, lipid and protein do not increase with an increase in the risk parameters of MetS. However, it is indeed 
high in MetS with 3 and more risk parameters. Presence of 2 or 1 Risk also increases OS compared to 0 Risk. There is 
oxidative stress damage in MetS to lipid and protein but DNA damage was of significant consequence.  
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Aerobic respiration is obligated to generate reactive 
oxygen species (ROS) in the body. The generation of 
small amounts of ROS and free radicals play 
important roles in cellular signaling processes 
essential for a normal functioning of the human 
body
1
. However, when the ROS production 
supersedes the cellular capacity to detoxify them by 
antioxidants due to an unfavorable environment, the 
subtle balance between oxidation and antioxidation is 
lost and oxidative stress (OS) ensues. OS is an early 
event and at the same time also a consequence in the 
pathology of MetS which is a cluster of 
cardiovascular disease risk factors in one individual 
comprising of diabetes or pre-diabetes, abdominal 
obesity, high cholesterol and high blood pressure, all 
recognized easily by simple clinical measures. ROS 
of vascular origin plays an important causal role in the 
development of obesity via NADPH oxidase
2
. A 
robust number of studies also demonstrates that all the 
five classical risk factors of MetS increase the 
production of ROS. Poor diet and a lack of physical 
activity which are the risk factors of MetSare the 
internal sources for OS. High caloric intake, 
composed of glucose, lipid, or protein beyond the 
body’s energy requirement causes an increase in the 
generation of ROS by Leukocytes, p47phox protein, a 
key protein in the enzyme NADPH oxidase, 
activation of nuclear factor-κB and inflammation3-6. 
Different macronutrient induces a distinct pattern of 
increase in ROS generation
7
. OS builds up to damage 
macromolecules and targets of oxidative damage are 
DNA, protein, lipid and carbohydrate
8
.  
8-hydroxyguanine, carbonyls, malondialdehyde and, 
advanced glycation end products are the few 
examples of oxidative damages to the bio-molecules, 
respectively. ROS leading to protein oxidation include 











) andnon radical 
species such as hydrogen peroxide (H2O2), 








modifications caused by ROS/RNS include formation 
of carbonyls, dityrosine and nitrated and chlorinated 
tyrosine. Oxidative stress induced peroxidation of 
membrane lipids can lead to alterations in the 
biological properties of the membrane, such as the 








bound receptors or enzymes, which in turn may 
impair normal cellular function and increase tissue 
permeability
11
. Not all reactive species (O2
•–
 and 
H2O2) react with DNA bases or with the deoxyribose. 
However, the most important oxygen-free radical 
causing damage not only to DNA but also to lipids 
and protein is the hydroxyl radical (HO
•−
). Lipid 
peroxidation products including the aldehydes also 
react with DNA, phospholipids and proteins, to 
generate stable products that are thought to contribute 
to the pathogenesis of numerous diseases. Chemical 
or immunochemical quantification of these relatively 
stable products as a biomarker of OS is available and 
numerous numbers of these markers have been 
studied in disease conditions.ROS/RNS are generally 
too reactive and/or have a short half-life period. 
However, molecular products formed from the 
reaction of ROS/RNS with biomolecules instead are 
generally considered more stable than ROS/RNS 
themselves
11-14
. Chen S (2012) measured MDA and 
Antioxidant enzyme activities to understand the 
relationship between Oxidative stress in Metabolic 
Syndrome
15
. Similarly, a LIPGENE study (2013) 
analyzed Lipid peroxidation product and Hydrogen 
peroxide to determine Oxidative Stress in metabolic 
syndrome
16
 while Butkowskiet al. (2016) investigated 
Glutathione and 8-hydroxy-2-deoxyguanosine in 
chronic hyperglycemia
17
. The literature is very 
heterogeneous and does not report on the relative 
oxidative damages caused to DNA, lipid and protein. 
Added to the above and the non-existent data from 
distant outreaches of the nation, we propose to study 
the redox status of individuals by measuring the 
concentrations of these stable oxidation target 
products in those with MetS and those progressing 
towards MetS. We have emphasized on  
8-OH-deoxyguanosine, as a marker of DNA oxidative 
damage, malondialdehyde (MDA), hydroxynonenal 
(HNE) as a marker of lipid oxidative damage and 
protein carbonyl (PC), advanced oxidation protein 
product (AOPP) as a marker of protein oxidative 
damage including total antioxidant capacity. We 
investigated if the oxidation markers of DNA, lipid 
and protein increased exponentially with an increase 
in the risk parameters of MetS. 
 
Materials and Methods  
The study was a hospital-based cross-sectional 
design that was conducted in the Department of 
Biochemistry, Central Referral Hospital, Sikkim 
Manipal Institute of Medical Sciences. Sample 
selection and collection were performed in the 
hospital’s phlebotomy lab after obtaining due 
permission from the Institutional Ethics Committee 
[IEC/192/12-05(a)]. Outpatients (also including those 
who came for annual health checkups between  
March 2014-December 2016 with a requisition for 
biochemical investigations like fasting blood sugar and 
lipid profile were enrolled for the study. Patients were 
informed of the study and those willing were asked  
for a signed consent. General information on age, sex, 
anthropometric measurements, ethnicity, smoking/alcohol 
habits, present medications and history of past and 
present diseases were recorded.  
 
Blood pressure and waist circumference of all 
participants were measured by standardized procedures. 
Blood pressure was recorded by an auscultatory method 
using sphygmomanometer. After the patient was 
comfortably seated an average of two readings was 
taken at an interval of 2 min. Waist circumference was 
measured using a non-stretchable tape at the umbilical 
scar level in between lowest rib and iliac crest.  
 
A 3 mL fasting blood sample of all participants were 
drawn by the hospital phlebotomists and was used to 
measure fasting blood sugar and lipid profile using 
ERBA Kits for an ERBA Manheim EM 200 full auto 
analyzer. The blood sample was used for estimating 
DNA oxidation marker: 8-hydroxy-deoxy-Guanine  
(8-OHdG). 8-OH-dGwas assayed by EIA kit from 
CAYMAN chemicals USA. The assay is based on the 
competition between oxidatively damaged guanine 
species and 8-OH-dG-acetylcholinesterase conjugate 
(DNA/RNA oxidative damage tracer) for a limited 
amount of DNA/RNA Oxidative Damage Monoclonal 
Antibody. Because the amount of tracer is held 
constant while the concentration of oxidatively 
damaged guanine varies, the amount of tracer that is 
able to bind to the monoclonal antibody will be 
inversely proportional to the concentration of the 
oxidatively damaged guanine in the well. 
 
Lipid peroxidation marker Hydroxynonenal was 
assayed by EIA kit from CELL BIOLABS, INCUSA. 
HNE in the sample binds to HNE conjugate  
pre-absorbed on the ELISA plate. An anti-HNE 
polyclonal antibody is added after incubation, followed 
by an HRP conjugated secondary antibody which was 
then determined by comparison with a predetermined 
HNE-BSA (g/mL) standard curve at 450 nm; 
malondialdehyde was assayed by colorimetric kit from 
CAYMAN chemicals, USA. According to the 
procedure, the TBA adduct formed by the reaction of 




MDA and TBA under high temperature (90-100C) 
and acidic condition was measured colorimetrically at 
530-540 nm expressed in M concentration. 
Protein oxidation marker: Advanced Oxidation 
Protein Product was assayed by a method described by 
Witko-Sarsat V et al.
18
. The unknown AOPP-containing 
samples or Chloramine standards were mixed with 
Potassium Iodide (an initiator) that begins a color 
development process. After a brief incubation, a stop 
solution Glacial Acetic Acid was added and the 
samples and Chloramine standards were read with a 
standard spectrophotometer.  
Protein carbonyl on the other hand was determined 
by Buss IH
19
. The protein carbonyl colorimetric assay 
utilizes the DNPH reaction to measure the protein 
carbonylcontent in samples. The amount of protein-
hydrazone produced is quantified spectrophotometrically 




Participants (male and female ≥ 20 yrs of age) were 
randomly evaluated for MetS risk parameters following 
Harmonized IDF definition
20
. MetS is diagnosed  
when the patient has three or more of the following five 
risk parameters; Fasting glucose ≥ 100 mg/dL 
(or receiving drug therapy for hyperglycemia), 
Blood pressure ≥ 130/85 mmHg (or receiving drug 
therapy for hypertension), Triglycerides ≥ 150 mg/dL 
(or receiving drug therapy for hypertriglyceridemia), 
HDL-C <40 mg/dL in men or < 50 mg/dL in women  
(or receiving drug therapy for reduced HDL-C).Waist 
circumference is ethnic specific: ≥ 90 cm in men or  
≥ 80 cm in women for Asian Indians]. Based on the 
subject selection criteria and presence of the number of 
risk factors of MetS, participants were subdivided into  
4 study groups (Table 1). 
a) 3 Risk/MetS: were MetS diagnosed subjects that 
had 3 or more risks factors, for example, large waist 
circumference + elevated blood sugar + elevated 
blood pressure. 
b) 2 Risk: were those having 2 Risk factors, for 
example, elevated blood pressure + raised fasting 
blood sugar. 
c) 1 Risk: were those having 1 Risk factor for example 
only a large waist circumference. 
d) 0 Risk: were those having 0 Risk factor. 
 
The subject selection criteria 
Inclusion criteria: Participants ≥ 20 years of age 
and anyone not under long-term medication for any 
diseases other than for Diabetes, Hypertension, 
Dyslipidemia were included. Exclusion criteria: 




Sample size for pair wise comparison was 
calculated according to Wang H et al.
21
. Assuming 
5% level of significance (α= 0.05), power 80%  
(β= 0.84); mean difference (δ) of 67.5 and standard 
deviation (σ) of 60.2, a sample size (n) =12 was found 
in each group; 
 




However, we considered 40 participants under each 
group (Group 1; 3 Risk /MetS =40, Group 2; 2 Risk= 
40, Group 3; 1 Risk =40 and Group4; 0 Risk =40).  
 
Statistical analysis 
All Statistical analysis was performed using SPSS 
20 software package (IBM SPSS Statistics).Data were 
inspected for normal distribution and accordingly 
appropriate tests were adopted A Kruskal-Wallis test 
was conducted to determine significant differences in 
Table 1 — Metabolic syndrome risk parameters in the four study groups 
 Metabolic syndrome (n=40)  Non metabolic syndrome (n=120) 
 Subjects with 3 or 
more Risk for MetS 
(n=40) 
Subjects with 2 Risk 
for MetS (n=40) 
Subjects with 1 Risk 
for MetS (n=40) 
Subjects with 0 Risk 
for MetS/Control 
group (n=40) 
Age (in years) 47 ± 11 45 ± 13 39  ±10 33  ± 9 
Waist Circumference (cm) 95.5 ± 8.2 95.1 ± 8.6 88.5 ± 9.3 82.3 ±  7.0 
Systolic blood Pressure  (mmHg) 130 ± 14 124 ± 10 120 ± 6 118 ±  6 
Diastolic blood pressure (mmHg) 85 ± 7 83 ± 8 79 ± 4 77 ± 7 
Fasting blood sugar (mg/dL) 131.7 ± 120 106 ±56 93 ± 11 86  ± 10 
Triglyceride  (mg/dL) 196.1  ± 120 139.9 ± 59 158.6 ± 157 96.9 ± 16 
HDL-C (mg/dL) 50.4 ± 18 51.8 ± 15 61.7 ± 24 54.9 ± 16 
Values are mean± SD 




the oxidation products of Lipid, Protein, DNA and 
Total Antioxidant Capacity across groups with  
―3 Risk/MetS, 2 Risk, 1 Risk and 0 Risk‖ for MetS. A 
P value of < 0.05 was taken statistically significant. 
Pair wise comparisons of the oxidation markers were 
performed for those significant in the Kruskal-Wallis 
test using Dunn’s procedure with a Bonferroni 
correction for multiple comparisons and for this 
statistical significance was accepted at P <0.012. 
Values were median scores unless otherwise stated. 
 
Results  
PC and AOPP, as a marker of protein oxidative 
damage, differed significantly across the four study 
groups at P =0.009 and 0.013, respectively, (Fig. 1A). 
MDA & HNE as a marker of lipid peroxidation did not 
differ significantly across the four study group at  
P =0.608 and 0.456, respectively, (Fig. 1B). However, 
DNA oxidative damage product ―8-OH dG‖ differed 
significantly at P =0.007 (Fig. 1C). TAC as well did not 
show significant difference across the group at P =0.199 
(Fig. 1D). Subsequently, to discover which group is 
different to which other group, a pair wise comparison 
were performed for statistically significant protein 
oxidative and DNA oxidative damage markers.  
This post hoc analysis revealed statistically significant 
differences; in 8-OH dG between 0 Risk-3 Risk, at  
P =0.005 but not between 0 Risk-2 Risk and  
0 Risk-1 Risk (Table 2). Likewise, PC and AOPP did 
not differ significantly between 0 Risk -3 Risk,  
0 Risk -2 Risk and 0 Risk -1 Risk (Table 2). 
 
Discussion  
We tested stable but indirect markers of oxidative 
damage products of macromolecules including MDA 
and Hydroxynonenalas lipid peroxidation product; 
Advanced Oxidation Protein Product and Protein 
Carbonyl as protein oxidation marker and 8-OHdG as 
DNA oxidation marker and examined their status across 
the four groups with 3 Risk, 2 Risk, 1 Risk and 0 Risk 
for MetS, so as to determine if the level of oxidative 
damage markers increased with an increase in the 
number of risk factors of MetS. Upon careful 
examination, we observed ―oxidation markers of DNA, 
lipid and protein did not increase with an increase in the 
risk parameters of MetS‖. The lipid per oxidation 
marker Malondialdehyde and 4-Hydroxynonenal, the 
two most widely used markers for lipid peroxidation and 
oxidative stress in vivo unfortunately did not 
demonstrate statistically significant difference on 
clustering of the risk factors, represented by those 
having 3 Risk, 2 Risk, 1 Risk and 0 Risk for MetS.  
 
 
Fig. 1 — (A) Comparison of Advanced Oxidation Protein 
Product (AOPP) and Protein carbonyl (PC) in 3 Risk, 2 Risk,  
1 Risk and 0 Risk of MetS by Kruskal -Wallis H-test 
(significant at P <0.05). AOPP; statistically significant,  
P =0.013*; and PC (nM/mL); statistically significant,  
P =0.009*; (B) Comparison of Malondialdehyde (MDA) and 
Hydroxynonenal (HNE). MDA (M/L); statistically 
insignificant, P =0.608; and HNE (g/mL); statistically 
insignificant, P =0.456; (C) Comparison of DNA Oxidation 
product; 8-OHdG (pg/mL) across groups with statistically 
significant, P =0.007*; and (D) Comparison of TAC (CRE); 
statistically insignificant, P =0.119 




Oxidative stress also increases protein oxidation
22
. 
Protein carbonyl is generated on direct oxidative 
damage to the protein backbone, specifically to amino 
acids such as Lysine, Arginine, Histidine, Proline, 
Glutamic acid and Threonine, or by binding of 
aldehyde produced from lipid peroxidation such as  
4-HNE or acrolein
22,23
. AOPP on the other hand can 
be generated by chlorinated oxidants such as 
chloramines or hypochlorous acid
18
 and neutrophills 
which constitute the most important source of 
chlorinated oxidants due to their high content in 
myeloperoxidase is reported to be involved in plasma 
AOPP formation
24
 but once again AOPP and PC as a 
marker of protein oxidation in MetS did not 
demonstrate significant differences between those 
with the syndrome and those without the syndrome. 
Nevertheless, it was noteworthy that although 
statistically insignificant the level of protein and lipid 
peroxidation markers were higher in the 3 Risk, 2 Risk 
and 1 Risk group compared to the 0 Risk group. 
Biomarkers of Oxidative Stress Study (BOSS), 
using acute CCl4 poisoning in rodents as a model for 
OS, has demonstrated that 8OHdG in urine is a 
potential candidate as a general biomarker of oxidative 
stress
25
 of the markers tested for significant differences 
across the study group, only DNA damage marker,  
8-OHdG demonstrated significant statistical difference 
in the study population despite their having been on 
blood pressure and glucose-lowering medications. This 
difference was found between 3 Risk-0 Risk group. In 
other words, 8-OHdG level was higher in those 
categorized MetS (3 Risk group) when compared to 
those categorized control (0 Risk). This oxidized 
guanine species is the by-product released during the 
repair of the oxidative damage to guanine on both 
DNA and RNA. Furthermore, guanosine is the most 
oxidized among the DNA nucleobases
26
. Its level was 







. There is 
indeed a cumulative and synergistic effect of the risk 
factors of MetS, clustering of 3 and more risks factors 
of MetS has a greater effect on DNA damage than 
those with 0 Risk possibly due to tremendous OS
32
 put 
forth by the risk factors (Fig. 1C). Presence of either a 
2 Risk or 1 Risk increased OS erratically. If presence 
of even a single risk factor increased OS as much as 
those with 2 Risk was unclear from our current 
experiment. Lee J et al. demonstrated oxidative DNA 
damage as illustrated by 8-OHdG occurred more in 
their hypertensive patients
27
.Gursatej Gandhi et al. also 
reports significant DNA damage differences in their 
hypertensive and normotensive patients
33
. All of this 
implies hypertension associated with oxidative stress is 
the reason for the genomic instability. Low levels of 
HDL cholesterol increase the risk of heart disease. And 
finally, abdominal obesity measured using a simple 
non-stretchable tape at the umbilical scar level is 
known to increase DNA damage by multiple 
mechanisms. Obese people often have chronic low-
level inflammation, which can, over time, cause DNA 
damage. Secondly, adipose tissue produces excess 
amounts of estrogen and inflammatory cytokines which 
have been associated with increased risks of cancers
34
. 
Infact all the 5 Risk parameters of MetS contributes 
towards OS and consequently induces DNA damage. 
Further, estimation of Total Antioxidant Capacity 
(TAC), that was performed to understand the overall 
redox status in the study participants, did not differ 
significantly across the groups that had 3 Risk, 2 Risk, 
1 Risk and 0 Risk for MetS. Our findings illustrated a 
completely opposite TAC situation, wherein instead of 
participants under the 0 Risk category, participants 
those in 3 Risk, 2 Risk and 1 Risk category had a 
higher TAC status (Fig. 1D). Mates JM and colleagues 
proposed when OS arises as a consequence of a 
pathologic event, a defense system promotes the 
regulation and expression of antioxidant enzymes
35
. 
Aouacheri O et al. reported SOD activity increased 
markedly in Type 2 Diabetic patients when compared 
to healthy subjects
36
. Another study conducted by 
Gupta S et al. showed that in the early stages of CAD, 
Superoxide Dismutase and Catalase levels increased to 
protect and prevent lipid peroxidation whereas they 
decreased significantly with the worsening of the 
Table 2 — Post-hoc analysis for multiple comparisons between  
0-1, 0-2, 0-3 Risk for PC, AOPP  
and 8-OHdG (Adjusted P-values are presented) 
 Significance 
Protein carbonyl   
0 Risk – 1 Risk 0.276 
0 Risk – 2 Risk 1.000 
0 Risk – 3 Risk  0.035 
Advanced Oxidation Protein Product 
0 Risk – 1 Risk 0.012 
0 Risk – 2 Risk 0.404 
0 Risk – 3 Risk  1.000 
8-hydroxy, 2-deoxy guanosine 
0 Risk – 1 Risk 0.416 
0 Risk – 2 Risk 1.000 
0 Risk – 3 Risk  0.005* 
*Significant at P<0.012 
 






. Hence if the antioxidant enzymes can rise in 
response to early OS so should the non enzymatic 
antioxidant. TAC assays in the plasma are a measure of 
low molecular weight, chain-breaking antioxidants that 
excludes the contribution of antioxidant enzymes and 
metal binding proteins. 
 
Conclusion 
Oxidative stress markers of DNA, lipid and protein 
do not increase with an increase in the risk parameters 
of MetS. However, it is indeed high in those 
diagnosed with MetS with 3 and more risks, 
compared to those with 0 Risk. Presence of 2 or  
1 Risk also increases OS compared to 0 Risk. There is 
oxidative stress damage in MetS to lipid and protein 
but DNA damage was of significant consequence. 
The nucleic acid is not only targeted by the direct 
markers of OS such as hydroxyls radical but the 
oxidation products obtained upon oxidative damage to 
proteins and lipid induces additional harm to the 
nuleic acid to increase the damage load. 
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